Metrics to compare | OBI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipOBIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.5x | −3.0x | −0.3x | |
PEG Ratio | −0.52 | −0.02 | 0.00 | |
Price/Book | 38.5x | 1.7x | 2.6x | |
Price / LTM Sales | 50.7x | 11.9x | 2.9x | |
Upside (Analyst Target) | - | 225.8% | 56.7% | |
Fair Value Upside | Unlock | −6.2% | 10.2% | Unlock |
Ondine Biomedical Inc., a life-sciences company, engages in the development of activated antimicrobial therapies for the prevention and treatment of infections in Canada and internationally. Its primary product is Steriwave, a non-invasive, nurse-administered treatment that eliminates harmful bacteria, viruses, and fungi from the nose. In addition, the company offers a pipeline of photodisinfection products for various indications, including chronic sinusitis, ventilator-associated pneumonia, burns and other indications. Ondine Biomedical Inc. was incorporated in 1996 and is headquartered in Vancouver, Canada.